Covid-19 patients to feature in trial on whether natural protein can reduce severe inflamation

Critically ill Covid-19 patients in Irish hospitals will be involved in a trial to see if severe inflammation can be reduced using a naturally produced human protein.
Covid-19 patients to feature in trial on whether natural protein can reduce severe inflamation
Mon, 29 Jun, 2020 - 19:44
Evelyn Ring

file image
file image

Critically ill Covid-19 patients in Irish hospitals will be involved in a trial to see if severe inflammation can be reduced using a naturally produced human protein.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Irish universities continue to probe extent of cyberattack on Canvas learning platform Irish universities continue to probe extent of cyberattack on Canvas learning platform
Cost of electricity: halogen bulb and twenty Euro notes Energy suppliers not making 'excessive' profits from soaring gas and electricity prices, watchdog says
Weather 'time machine' shows daily conditions for past 86 years Weather 'time machine' shows daily conditions for past 86 years
CoronavirusPlace: IrelandPlace: DublinPlace: GalwayPlace: BeaumontPerson: Gerry McElvaneyPerson: Ger CurleyPerson: McElvaneyOrganisation: Royal College of SurgeonsOrganisation: RCSI University of Medicine and Health SciencesOrganisation: RCSI
<p>More than 100 delegates representing the army, naval service, and air corps, will debate a record 70-plus motions at the PDForra conference this week. File picture: Eamonn Farrell/RollingNews</p>

'Astronomically high vacancy numbers' due to Defence Forces underinvestment

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited